COMPANY
About US
History
R&D
Pipeline
Intellectual Property
Organization
BUSINESS
Precision Medical
Al Platform
Partner
CONTACT
Contact
PUBLIC
Notice
News
Library
EN
KO
COMPANY
About US
History
R&D
Pipeline
Intellectual Property
Organization
BUSINESS
Precision Medical
Al Platform
Partner
CONTACT
Contact
PUBLIC
NOTICE
NEWS
Library
PUBLIC
Notice
News
library
NEWS
전체
전체
제목
내용
Signs an MOU with Medisapiens to develop new drugs based on AI
2022-01-20
ANLBIO selects dementia treatment development tasks by the Dementia Overcoming Research and Development Project
2021-01-11
ANLBIO's treatment for dementia has been patented in the U.S
2021-01-11
ANLBio selects 'AD gene therapy' government task
2021-01-11
Development of ANLBIO, miRNA-regulated AD gene therapy
2021-01-11
1
